LORACARBEF: 36 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
36
Total FAERS Reports
0
Deaths Reported
2
Hospitalizations
36
As Primary/Secondary Suspect
Apr 5, 1996
FDA Approved
Discontinued
Status
FDA Application: 050667 ·
First Report: 20031003 · Latest Report: 20031003
What Are the Most Common LORACARBEF Side Effects?
#1 Most Reported
Drug hypersensitivity
33 reports (91.7%)
#2 Most Reported
Rash
3 reports (8.3%)
#3 Most Reported
Tubulointerstitial nephritis
2 reports (5.6%)
All LORACARBEF Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 33 | 91.7% | 0 | 0 |
Who Reports LORACARBEF Side Effects? Age & Gender Data
Gender: 88.2% female, 11.8% male. Average age: 49.9 years. Most reports from: US. View detailed demographics →
Is LORACARBEF Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 1 | 0 | 0 |
Official FDA Label for LORACARBEF
Official prescribing information from the FDA-approved drug label.